Search

SGN-CD33A Combined with Hypomethylating Therapy Produces High Remission Rates among Older Patients with AML

Acute myeloid leukemia (AML) is an aggressive form of blood cancer in which the majority of cases express CD33 on the surface of the leukemia cells.

Read more

Late-Breaking Abstract Submission

Late-breaking abstract procedureThe official late-breaking abstract submission was open from May 3 to 9, 2024 (09:00 CEST). The full late-breaking abstract submission terms & conditions can be found here.

Read more

First Hybrid HOPE meeting in Bangkok, Thailand - a report

Highlights of Past EHA (HOPE) Asia 2022

September 2-3, 2022 – Bangkok, Thailand

Meeting chairs

A Almeida, President, European Hematology Association (EHA)
G Gaidano, Chair Global Outreach Committee, European Hematology Association (EHA)
P Rojnuckarin, President, Thai Society of Hematology (TSH)
S Hongeng, Vice President, Thai Society…

Read more

Chronic Myeloid Leukemia

The objective of this SWG is the cure of Chronic Myeloid Leukemia (CML) by cooperative research.

Read more

Enjoy Amsterdam like a Local

EHA24 is just around the corner, and we could not be more excited about the Congress program (especially the YoungEHA track – great science, interesting discussions, and food for thought are waiting for you)! As attending the Congress is also…

Read more

A brand new EHA website!

You may already have noticed the new EHA look & feel.  We are proud to share it with you already.  We are currently migrating all our pages and related information.

Read more

Expert opinions for COVID-19 vaccination in patients with non-malignant hematologic diseases

Carlo Dufour, Helen Papadaki, Alan Warren, Colm Bradley, Cristina Mecucci, Jan Palmblad, Cornelia Zeidler, Francesca Fioredda, Sam Salek, Brigitte  Schlegelberger and Daniela Guardo, on behalf of the EHA SWG on Granulocytes and Constitutional Marrow Failure Disorders; Carlo L.

Read more